Goldman Sachs Asks ‘Is Curing Patients A Sustainable Business Model?’

CBS Local — Investment banking giant Goldman Sachs is reportedly asking some very cold questions about the healthcare industry and whether it’s a good business move to cure diseases.
In an April 10 financial report titled “The Genome Revolution,” company analysts allegedly posed the question “is curing patients a sustainable business model?” The report broke down the pros and cons of new gene therapy treatments being worked on by biotech companies. T